These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
497 related articles for article (PubMed ID: 27517633)
1. Plasma miR-324-3p and miR-1285 as diagnostic and prognostic biomarkers for early stage lung squamous cell carcinoma. Gao X; Wang Y; Zhao H; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X Oncotarget; 2016 Sep; 7(37):59664-59675. PubMed ID: 27517633 [TBL] [Abstract][Full Text] [Related]
2. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
3. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
4. Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma. Maia D; de Carvalho AC; Horst MA; Carvalho AL; Scapulatempo-Neto C; Vettore AL J Transl Med; 2015 Aug; 13():262. PubMed ID: 26264462 [TBL] [Abstract][Full Text] [Related]
5. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma. Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849 [TBL] [Abstract][Full Text] [Related]
6. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. Ayaz L; Görür A; Yaroğlu HY; Ozcan C; Tamer L J Cancer Res Clin Oncol; 2013 Sep; 139(9):1499-506. PubMed ID: 23817697 [TBL] [Abstract][Full Text] [Related]
8. Serum expression of selected miRNAs in patients with laryngeal squamous cell carcinoma (LSCC). Lucas Grzelczyk W; Szemraj J; Kwiatkowska S; Józefowicz-Korczyńska M Diagn Pathol; 2019 May; 14(1):49. PubMed ID: 31138255 [TBL] [Abstract][Full Text] [Related]
9. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
10. Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma. Falco M; Tammaro C; Cossu AM; Takeuchi T; Tufano R; Ceccarelli M; Scafuro G; Zappavigna S; Grimaldi A; Scrima M; Ottaiano A; Savarese G; Fico A; Mesolella M; Fasano M; Motta G; Massimilla EA; Addeo R; Ricciardiello F; Caraglia M; Misso G J Transl Med; 2024 Jul; 22(1):647. PubMed ID: 38987822 [TBL] [Abstract][Full Text] [Related]
11. Identification of a three-miRNA signature as a blood-borne diagnostic marker for early diagnosis of lung adenocarcinoma. Wang Y; Zhao H; Gao X; Wei F; Zhang X; Su Y; Wang C; Li H; Ren X Oncotarget; 2016 May; 7(18):26070-86. PubMed ID: 27036025 [TBL] [Abstract][Full Text] [Related]
12. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239 [TBL] [Abstract][Full Text] [Related]
13. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma. Wang JL; Wang X; Yang D; Shi WJ Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279 [TBL] [Abstract][Full Text] [Related]
14. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252 [TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
16. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
17. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Zhou X; Wen W; Zhu J; Huang Z; Zhang L; Zhang H; Qi LW; Shan X; Wang T; Cheng W; Zhu D; Yin Y; Chen Y; Zhu W; Shu Y; Liu P Oncotarget; 2017 May; 8(21):34468-34480. PubMed ID: 28380431 [TBL] [Abstract][Full Text] [Related]
18. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
19. Integrated miRNA and mRNA expression analysis uncovers drug targets in laryngeal squamous cell carcinoma patients. Lapa RML; Barros-Filho MC; Marchi FA; Domingues MAC; de Carvalho GB; Drigo SA; Kowalski LP; Rogatto SR Oral Oncol; 2019 Jun; 93():76-84. PubMed ID: 31109699 [TBL] [Abstract][Full Text] [Related]
20. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]